Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The role of information system in multiple sclerosis management.
Non-Significant Associations Between Measures of Inhibitory Control and Walking While Thinking in Persons with Multiple Sclerosis.
CENTENARIAN RATES AND LIFE EXPECTANCY RELATED TO THE DEATH RATES OF MULTIPLE SCLEROSIS, ASTHMA AND RHEUMATOID ARTHRITIS AND THE INCIDENCE OF TYPE 1 DIABETES IN CHILDREN.
2015 Multiple Sclerosis Experts Summit.
Natalizumab in the pediatric MS population: results of the Italian registry.
Association between functional CD24 polymorphisms and susceptibility to autoimmune diseases: A meta-analysis.
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis.
Social support, depression, and physical disability: Age and diagnostic group effects.
Consistency in Administration and Response for the Backward Push and Release Test: A Clinical Assessment of Postural Responses.
Environmental factors and their regulation of immunity in multiple sclerosis.
Evaluation of new immunological targets in neuromyelitis optica.
Molecular pathogenesis of neuromyelitis optica.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.
Imaging of glutamate in the spinal cord using GluCEST.
Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.
Association of interleukin-1 gene polymorphisms with multiple sclerosis: a meta-analysis.
Multiple sclerosis as a cause of the acute vestibular syndrome.
Reproduction and the risk of multiple sclerosis.
Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab.
The Evaluation of the Retinal Nerve Fiber Layer in Multiple Sclerosis with Special-Domain Optical Coherence Tomography.
AAV1.NT-3 gene therapy for Charcot-Marie-Tooth neuropathy.
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study.
Outcome Measures for Individuals With Multiple Sclerosis: Recommendations From the American Physical Therapy Association Neurology Section Task Force.

Pages